JAGX

Jaguar Health, Inc. JAGX

JAGX
Jaguar Health, Inc. GRI
GRI Bio, Inc. CNSP
CNS Pharmaceuticals, Inc. BDRX
Biodexa Pharmaceuticals Plc SILO
Silo Pharma, Inc. INM
InMed Pharmaceuticals Inc. GNPX
Genprex, Inc. SXTP
60 Degrees Pharmaceuticals, Inc. CLDI
Calidi Biotherapeutics, Inc. CANF
Can-Fite BioPharma Ltd.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode JAGX GRI CNSP BDRX SILO INM GNPX SXTP CLDI CANF
6M -58.31 % -73.70 % -27.61 % -64.67 % -35.37 % -46.73 % -83.41 % -64.86 % -61.11 % -77.25 %
YTD -95.87 % -97.62 % -90.61 % -92.05 % -58.95 % -72.81 % -95.78 % -88.47 % -90.61 % -86.65 %
1Y -95.39 % -97.31 % -89.92 % -91.49 % -55.85 % -72.12 % -95.93 % -86.97 % -92.14 % -83.64 %
3Y -99.97 % -100.00 % -99.99 % -99.99 % -87.00 % -95.06 % -99.91 % -99.73 % -99.89 % -96.27 %
5Y -100.00 % -100.00 % -100.00 % -100.00 % 11.43 % -99.92 % -99.98 % -99.73 % -99.89 % -98.70 %
10Y -100.00 % -100.00 % -100.00 % -100.00 % 11.43 % -99.93 % -99.98 % -99.73 % -99.89 % -99.95 %
From the beginning -100.00 % -100.00 % -100.00 % -100.00 % 11.43 % -99.97 % -99.98 % -99.73 % -99.89 % -99.97 %

Dividend